IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Great Point Partners LLC

Q2 2025 Holdings

Filed 2025-08-14 | 26 holdings | $153.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Ionis Pharmaceuticals Inc(IONS)COM462222100$19.8M500,00012.8%
Rezolute Inc(RZLT)COM NEW76200L309$13.5M3,033,4628.8%
Amylyx Pharmaceuticals Inc(AMLX)COM03237H101$12.8M2,000,0008.3%
Legend Biotech Corp(LEGN)SPONSORED ADS52490G102$12.4M350,0008.1%
Abivax SA(ABVX)SPONSORED ADS00370M103$9.9M1,291,6176.4%
Neurogene Inc(NGNE)COM64135M105$7.3M485,8594.7%
Akebia Therapeutics Inc(AKBA)COM00972D105$7.2M1,985,9154.7%
Evolus Inc(EOLS)COM30052C107$6.6M720,1184.3%
Arcellx Inc(ACLX)COMMON STOCK03940C100$6.6M100,0004.3%
Xenon Pharmaceuticals Inc(XENE)COM98420N105$6.3M200,0004.1%
Akero Therapeutics Inc(AKRO)COM00973Y108$5.5M103,8483.6%
Jade Biosciences Inc(JBIO)COM NEW008064206$5.0M498,0543.2%
Cytokinetics Inc(CYTK)COM NEW23282W605$5.0M150,0003.2%
Immunovant Inc(IMVT)COM45258J102$4.2M262,1762.7%
Unicycive Therapeutics Inc(UNCY)COM NEW90466Y202$3.8M796,5582.5%
Kalvista Pharmaceuticals Inc(KALV)COM483497103$3.7M323,1702.4%
Taysha Gene Therapies Inc(TSHA)COM SHS877619106$3.5M1,500,0002.3%
DBV Technologies S A(DBVT)SPONSORED ADS23306J309$3.4M374,6792.2%
Zura BIO LTD(ZURA)CLASS A ORD SHSG9TY5A101$3.3M3,170,1942.2%
Upstream BIO Inc(UPB)COM91678A107$3.3M300,0002.1%
Context Therapeutics Inc(CNTX)COM21077P108$3.1M4,683,7112.0%
Centessa Pharmaceuticals PLC(CNTA)SPONSORED ADS152309100$3.0M225,0001.9%
Scholar Rock Hldg Corp(SRRK)COM80706P103$2.2M61,6071.4%
Promis Neurosciences Inc(PMNEUR)COM NEW74346M406$1.3M2,645,1280.8%
Pliant Therapeutics Inc(PLRX)COM729139105$986.0K850,0000.6%
Helix Acquisition Corp IICL A ORD SHSG4444H101$312.0K29,3810.2%